Appendix A: International Classification of Diseases, 10th Revision, Clinical Modification Codes (ICD-10) Utilized for VTE Events
|
|
|
- Piers Cain
- 6 years ago
- Views:
Transcription
1 Online Appendices to Mahan et al. External validation of a risk assessment model for venous thromboembolism in the hospitalised acutely-ill medical patient (VTE-VALOURR) (Thromb Haemost 2014; 112.4) Appendix A: International Classification of Diseases, 10th Revision, Clinical Modification Codes (ICD-10) Utilized for VTE Events ICD-10 Code I26 Pulmonary embolism I26.9 Pulmonary embolism without mention of acute cor pulmonale I80.0 Phlebitis and thrombophlebitis of superficial vessels of lower extremities I80.1 Phlebitis and thrombophlebitis of femoral vein I80.2 Phlebitis and thrombophlebitis of other deep vessels of lower extremities Deep vein thrombosis NOS I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified Embolism or thrombosis of lower extremity NOS I80.8 Phlebitis and thrombophlebitis of other sites I80.9 Phlebitis and thrombophlebitis of unspecified site I82.1 Thrombophlebitis migrans I82.8 Embolism and thrombosis of other specified veins I82.9 Embolism and thrombosis of unspecified vein 1
2 Appendix B: Exclusion Diagnoses Codes at Index Hospitalization ICD-10 Diagnosis Code Pregnancy O00.0 O99.8 Atrial Fibrillation and Flutter I48 Mental disorder F00.0 F99.0 S00.0 S99.9, T00.0-T07.0, T08.0 T14.9, T15.0 T 19.9, T20.0 T 32.9, T33.0 T 35.7, T T45.4, T T50.9, T51.0 T65.9, T , T T80.9, T T88.9, Trauma, acute spinal cord injury T T79.9, T90.0- T90.9, T91.0 T91.9, T92.0 T92.9, T93.0-T93.9, T94.0 T94.1, T95.0 T95.9, T97.0, T98.0, T98.2, V0.1.0 V99.9, W00.0 W99.9, X40.0, X41.0, X42.0, X43.0, X45.0 X99.0, Y10.0 Y36.9, Y85.0 Y89.9 2
3 Appendix C: Codes for Exclusionary Surgeries and Procedures within three months or during index hospitalization Operations on the nervous system Operations on the Sympathetic Nerves, Brachial Plexus, Phrenic Nerve, and Vagus Nerves Operations on the head and neck Operations on the upper arm, elbow, forearm, hand and wrist Operations on the Musculoskeletal system of the head, nasal cavity and sinuses Operations on the eye Other miscellaneous diagnostic and therapeutic procedures Operations on the ear CCI Procedure Code 1.AA.52.^^ - 1.AA.87.^^, 1.AB.52.^^ - 1.AB.87.^^, 1.AC.50.^^ - 1.AC.87.^^, 1.AE.09.^^, 1.AE.53.^^ - 1.AE.87.^^, 1.AF.52.^^ - 1.AF.87.^^, 1.AG.52.^^ - 1.AG.87.^^, 1.AJ.53.^^ - 1.AN.26.^^, 1.AN.52.^^ 1.AP.09.^^, 1.AP.52.^^ - 1.AW.09.^^, 1.AW.59.^^ - 1.AX.11.^^, 1.AX.16.^^, 1.AX.52.^^ - 1.AZ.94.^^, 1.BA.09.^^, 1.BA.53.^^ - 1.BA.87.^^, 1.BS.09.^^, 1.BS.11.^^, 1.BS.58.^^ - 1.BT.11.^^, 1.BT.58.^^ - 1.BX.11.^^, 1.BX.53.^^ - 1.BZ.94.^^ 1.BF.59.^^ - 1.BG.11.^^, 1BG.72.^^ - 1.BJ.09.^^, 1.BJ.53.^^ - 1.BK.09.^^, 1.BK.59.^^ 1.BB.11.^^, 1.BB.53.^^ 1.BB.87.^^, 1.BM.11.^^, 1.BM.58.^^ - 1.BQ.87.^^ 1.EA.55.^^ - 1EF.80.^^, 1.EG.74.^^ - 1.EL.05.^^, 1.EL.52.^^ - 1.EP.09.^^, 1.EP.58.^^ - 1.EQ.12.^^, 1.EQ.14.^^ - 1.EQ.26.^^, 1.EQ.52.^^ - 1.ET.03.^^, 1.ET.37.^^ - 1.EX.87.^^, 1.EY.52.^^ - 1.FD.12.^^, 1.FD.14.^^, 1.FD.52.^^ - 1.FE.29.^^, 1.FE.37.^^ - 1.FE.94.^^, 1.FF.53.^^ - 1.FF.89.^^, 1.FG.26.^^, 1.FG.52.^^ - 1.FH.87.^^, 1.FJ.26.^^, 1.FJ.52.^^ - 1.FM.91.^^, 1.FN.50.^^ - 1.FP.26.^^, 1.FP.53.^^ - 1.FQ.89.^^, 1.FR.52.^^ - 1.FR.89.^^, 1.FU.52.^^ - 1.FX.11.^^, 1.FX.26.^^, 1.FX.52.^^ - 1.FX.91.^^ 1.CC.07.^^ - 1.CD.87.^^, 1.CE.55.^^ - 1.CH.87.^^, 1.CJ.52.^^ - 1.CL.89.^^, 1.CM.59.^^ - 1.CN.12.^^, 1.CN.52.^^ - 1.CP.91.^^, 1.CQ.59.^^ - 1.CQ.87.^^, 1.CR.80.^^ - 1.CR.87.^^, 1.CS.52.^^ - 1.CS.87.^^, 1.CT.51.^^ - 1.CU.12.^^, 1.CU.50.^^ - 1.CX.14.^^, 1.CX.52.^^ - 1.CZ.26.^^, 1.CZ.37.^^ - 1.CZ.94.^^ 1.ZZ.71.^^, 2.AA.71.^^, 2.AC.70.^^ - 2.AC.71.^^, 2.AE.71.^^, 2.AF.70.^^ - 2.AF.71.^^, 2.AG.71.^^, 2.AJ.71.^^,2.AK.71.^^, 2.AN.71.^^, 2.AP.71.^^, 2.AW.71.^^, 2.AX.70.^^, 2.BA.70.^^ - 2.BA.71.^^, 2.BB.70.^^ - 2.BB.71.^^, 2.BD.70.^^ - 2.BD.71.^^, 2.BF.70.^^ - 2.BF.71.^^, 2.BG.70.^^ - 2.BG.71.^^, 2.BL.70.^^ - 2.BL.71.^^ 1.BD.11.^^, 1.BD.58.^^ - 1.BD.87.^^, 1.BD.59.^^ - 1.BD.87.^^, 1.DA.14.^^, 1.DA.52.^^ - 1.DE.14.^^, 1.DE.52.^^ - 1.DG.84.^^, 1.DJ.50.^^ - 1.DZ.94.^^ 3
4 Operations on the respiratory system Operations on the cardiovascular system Operations on the hemic and lymphatic system Operations on the digestive system Operations on the genito-urinary system Operations on the male genital organs 1.GA.50.^^ - 1.GC.59.^^, 1.GD.53.^^ - 1.GD.89.^^, 1.GE.37.^^ - 1.GH.84.^^, 1.GJ.26.^^, 1.GJ.50.^^ - 1.GJ.59.^^, 1.GJ.80.^^ - 1.GM.07.^^, 1.GM.26.^^, 1.GM.50.^^, 1.GR.58.^^ - 1.GR.91.^^, 1.GT.58.^^ - 1.GT.91.^^, 1.GW.59.^^ 1.GW.87.^^, 1.GX.80.^^ - 1.GX.87.^^ 1.HJ.76.^^ - 1.HZ.03.^^, 1.HZ.57.^^ - 1.IF.83.^^, 1.IJ.57.^^ - 1.IN.87.^^, 1.IS.57.^^ - 1.IS.87.^^, 1.JD.59.^^ - 1.KT.87.^^, 1.KV.54.^^ - 1.KV.80.^^, 1.KY.50.^^ - 1.LD.84.^^, 1.LZ.37.^^ - 1.LZ.38.^^ 1.MB.87.^^, 1.MC.87.^^ - 1.MC.91.^^, 1.MD.87.^^ - 1.MD.89.^^, 1.ME.87.^^ - 1.ME.89.^^, 1.MF.87.^^, 1.MG.87.^^ - 1.MG.89.^^, 1.MH.87.^^ - 1.MH.89.^^,1.MJ.87.^^ - 1.MJ.91.^^, 1.MK.87.^^ - 1.MK.89.^^, 1.ML.59.^^ - 1.MN.51.^^, 1.MN.59.^^ - 1.MN.87.^^, 1.MP.50.^^ - 1.MP.51.^^, 1.MP.59.^^ - 1.MP.87.^^, 1.MR.50.^^ - 1.MR.51.^^, 1.MR.59.^^ - 1.MR.91.^^, 1.MS.50.^^ - 1.MS.51.^^, 1.MS.59.^^ - 1.MS.91.^^, 1.MZ.94.^^ 1.NA.56.^^ - 1.NA.92.^^, 1.NE.50.^^ - 1.NE.80.^^, 1.NF.59.^^ - 1.NF.92.^^, 1.NK.56.^^ - 1.NK.87.^^, 1.NM.56.^^ - 1.NM.91.^^, 1.NP.58.^^ - 1.NP.86.^^, 1.NQ.56.^^ - 1.NQ.89.^^, 1.NT.56.^^ - 1.NT.87.^^, 1.OA.56.^^ - 1.OA.87.^^, 1.OB.59.^^ - 1.OB.89.^^, 1.OD.52.^^ - 1.OD.89.^^, 1.OE.37.^^ - 1.OE.89.^^, 1.OJ.26.^^, 1.OJ.52.^^ - 1.OK.91.^^, 1.OT.38.^^ - 1.OW.89.^^, 1.OZ.94.^^ 1.PB.52.^^ - 1.PB.89.^^, 1.PC.51.^^ - 1.PC.91.^^,1.PE.50.^^ - 1.PC.87.^^, 1.PG.50.^^ - 1.PG.89.^^, 1.PL.53.^^ - 1.PM.11.^^, 1.PM.26.^^, 1.PM.53.^^ - 1.PM.92.^^, 1.PQ.53.^^ - 1.PQ.89.^^, 1.PV.50.^^ - 1.PV.80.^^, 1.QE.26.^^, 1.QE.52.^^ - 1.QE.89.^^, 1.QG.26.^^, 1.QG.52.^^ - 1.QJ.89.^^, 1.QM.52.^^ - 1.QQ.89.^^, 1.QT.26.^^, 1.QT.50.^^ - 1.QZ.94.^^ 4
5 Operations on the female genital organs Operations on the musculoskeletal system Operations on the integumentary system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
6 Appendix D: Codes for Inclusion in the VTE and Control Cohorts at Discharge Date ICD-10-CM Diagnosis Code Heart failure I11.0, I13.0, I13.2, I50.0 I 50.9 Thromboembolic stroke I63.0 I63.9, I64, I69.3 Cancer C15.0 D0.9.9 Severe lung Disease Acute infection Rheumatic inflammatory disease J40.0 J95.0, J95.4 -J99.8 A00.0 A99.9, B00.0 B19.9, B B99.9, J00.0 J22.9, L00.0 L08.9, M00.0 M01.8, M63.0 M63.8, I00.0 I02.9, I05.0 to I09.9, Inflammatory bowel disease K50.0 K52.9 Diabetes mellitus, pancreatitis, and cholecystitis E10 E14, K81.0 K 81.9, K85.0 K85.9, K86.0 K86.1 6
7 Appendix E: Logistic regression models adjusting for any or appropriate use of thromboprophylaxis. Parameter Estimate Standard Error Wald Chi-Square Pr > ChiSq AUC Model Intercept <.0001 score <.0001 VTE prophylaxis Model Intercept <.0001 score <.0001 Appropriate VTE prophylaxis Model Intercept <.0001 score <
Spherical Bearings Heavy Duty Equipments
Spherical Bearings Heavy Duty Equipments Highlights Quality Service Price Wbf Replacement Parts adaptableto > Caterpillar >Komatsu >Volvo 1 WBF SPHERICAL BEARINGS adaptable to Caterpillar Part No. Description
(43) Publication date: 04 September 2014 ( ) (22) Filing Date: 27 February 2014 ( )
(54) Title (EN): INCOHERENT TYPE-III MATERIALS FOR CHARGE CARRIERS CONTROL DEVICES (54) Title (FR): MATÉRIAUX DE TYPE III INCOHÉRENTS POUR DISPOSITIFS DE RÉGULATION DE PORTEURS DE CHARGES (72) Inventor(s):
WO 2012/ A3. 15 November 2012 ( ) P O P C T
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International
Declaration of conformity Adapter
Declaration of conformity acc. to VO (EG) 1935/2004 and VO (EU) 10/2011 as well as acc. to FDA Document ID: 34466 Editing status: 2017-05-19 2 CFR FDA stands for Food and Drug Administration, a U.S. authority.
Declaration of conformity VEGABAR 82
Declaration of conformity acc. to VO (EG) 1935/2004 and VO (EU) 10/2011 as well as acc. to FDA and USP Class VI as well as ADI-free Document ID: 47480 Editing status: 2018-09-11 2 CFR FDA stands for Food
Recent Minima of 161 Eclipsing Binary Stars
Samolyk, JAAVSO Volume 38, 2010 85 Recent Minima of 161 Eclipsing Binary Stars Gerard Samolyk P.O. Box 20677; Greenfield, WI 53220; gsamolyk@wi.rr.com Received September 23, 2009; accepted September 25,
Our next questions are about Contingency Management.
II.B.04.01 01 Our next questions are about Contingenc t. Higgins and Petr (1999) describe Contingenc t as the sstematic reinforcement of desired behaviors and the withholding of reinforcement or punishment
SNUBBER CAPACITOR WITH AXIAL LEADS
Tan δ x 5 4 3 2 TEMPERATURE V/S DISSIPATION FACTOR 5 55 C 25 C +25 C +55 C Temperature +75 C + C ΔC FREQUENCY V/S % CHANGE IN CAPACITANCE C %.5 Highlights, Lw lss plyprpylene dielectric, High frequency
Calypso Application. License for card and portable objects.
Calypso Application License for card and portable objects. I N N O V A T R O N CalypsoLicense page 1 / 6 Innovatron, 27 rue de Bassano, 75008 Paris, France 1. License Policy General Presentation Innovatron
Appendix 1. Validation studies of Agency for Healthcare Research and Quality (AHRQ) patient safety indicator (PSI) Validated PSI and author
Appendix 1. Validation studies of Agency for Healthcare Research and Quality (AHRQ) patient safety indicator (PSI) Validated PSI and author Reference standard, Year of data PPV ( % of N) Conclusion made
P G K R P E W M G W L K P R G G A V N Y A R P L Q G R V T M T R D V Y S D T A F
Supplementary Figure 1 VRC01 45-08-110497H 45-08-212510H 45-08-511533H 45-08-541880H Q V Q L V Q S G G Q M K K P G E S M R I S C R A S G Y E F I D C T L N W I R L A CAGGTGCAGCTGGTGCAGTCTGGGGGTCAGATGAAGAAGCCTGGCGAGTCGATGAGAATTTCTTGTCGGGCTTCTGGATATGAATTTATTGATTGTACGCTAAATTGGATTCGTCTGGCC
(43) International Publication Date. 15 July 2010 ( ) WO 2010/ A3. (19) World Intellectual Property Organization International Bureau
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date (10) International
EOPS PROBATION STUDENT LIST
EOPS PROBATION STUDENT LIST Fall 2018 EOPS The following students have been placed on EOPS Probation due to their not satisfying the semester g.p.a. and/or semester units completed requirements of the
WO 2014/ A3 P O P C T. 6 February 2014 ( )
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International
Integrating ICD-10s in SmarTrack
Paul Russell BSN, RN Midas+ Solutions Educator Objectives Discuss change from ICD-9 to ICD-10 Define Indicator using ICD-10 Create a Worklist using ICD-10 2 2016 Midas+ Symposium May 23-25 Tucson, AZ 1
Molecular and Cellular Tumor Pathology Laboratory, Cancer Center Karolinska,
Antiproliferative Effects of 1α-OH-vitD 3 in Malignant Melanoma. Potential Therapeutic implications Lucia Spath 1,+, Alessandra Ulivieri 1,4+, Luca Lavra 1,4, Laura Fidanza 2, Marta Carlesimo 2, Maria
Enhanced safety in breast implants
Enhanced safety in breast implants Introduction Despite significant improvements in implant quality, rupture of breast implants is still possible If leak is suspected: Detection by palpation Experienced
Supplementary Figure 1. FACS analysis of cells infected with TY93/H5N1 GFP-627E,
Supplementary Figure 1. FACS analysis of cells infected with TY93/H5N1 GFP-627E, TY93/H5N1 GFP-627K, or the TY93/H5N1 PB2(588-759) virus library. To establish our GFP- FACS screening platform, we compared
P SERIES. 250 psi NFPA Pneumatic Cylinder TECHNICAL BROCHURE. Bore Sizes from 11/2 to 14
Actuation Solutions and Systems for the P SERIES 250 psi NFPA Pneumatic Cylinder Bore Sizes from 11/2 to 14 Actuation Solutions and Systems for the Design & Materials Temperature Ratings Low Temp. -54
QMS REPORT 146 JUNE 2008 QUALITY IN MICROBIOLOGY SCHEME
QMS REPORT 146 JUNE 2008 QUALITY IN MICROBIOLOGY SCHEME This report contains the results returned from the analysis of test materials distributed to laboratories in the June 2008 round. The despatch date
Supplementary Digital Content Section A Procedural codes to define study population
Supplementary Digital Content Section A Procedural codes to define study population Procedure CCI codes ORTHOPEDIC Total hip replacement 1.VA.53.LA-PN ; 1.VA.53.PN-PN Total knee replacement 1.VG.53 VASCULAR
Pharmacy Prior Authorization
Pharmacy Prior Authorization AETA BETTER HEALTH EW JERSE (MEDICAID) Anticoagulant Injectable (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review
Our next questions are about Multisystemic Therapy.
II.B.10.01 01 Our next questions are about Multisys Therapy. The National Registry of Evidene-Based Praties and Programs (NREPP) desribes Multisys Therapy as follows: Multisys Therapy () for juvenile offenders
Downloaded from journal.bums.ac.ir at 13:12 IRST on Monday March 11th 2019
187 " 15 Downloaded from journal.bums.ac.ir at 1:12 IRST on Monday March 11th 2019 2 1! "# - -.'!" #$ %& 9 %.. / 01$ 2 4& 5'6 78. - ) *+ %!,+ 9 9 26 >.+
EAST MULTICENTER STUDY DATA DICTIONARY
EAST MULTICENTER STUDY DATA DICTIONARY Does the Addition of Daily Aspirin to Standard Deep Venous Thrombosis Prophylaxis Reduce the Rate of Venous Thromboembolic Events? Data Entry Points and appropriate
Declaration of conformity VEGAVIB 61
Declaration of conformity acc. to VO (EG) 1935/2004 and VO (EU) 10/2011 as well as acc. to FDA Document ID: 32556 Editing status: 2016-10-25 2 CFR FDA stands for Food and Drug Administration, a U.S. authority.
Genetic Analysis of Allosteric Signaling in RhaR from Escherichia coli and Characterization of the VirF Protein from Shigella flexneri
Genetic Analysis of Allosteric Signaling in RhaR from Escherichia coli and Characterization of the VirF Protein from Shigella flexneri By Bria Collette Kettle Submitted to the graduate degree program in
Combined oral contraceptives and risk of venous thromboembolism: nested case control studies using the QResearch and the CPRD databases
Combined oral contraceptives and risk of venous thromboembolism: nested case control studies using the QResearch and the CPRD databases Yana Vinogradova, Carol Coupland, Julia Hippisley-Cox Web appendix:
LECTURE TOPIC ASSIGNMENTS
BASICS LECTURE TOPIC ASSIGNMENTS LECTURE TOPIC: ANATOMICAL TERMINOLOGY Read the textbook: Ch. 1: The Human Body: An Orientation Go To: Web Site > Folder: AnatTerm > A25terms09.pdf. Download the file &
Thin Film PV Technologies CIGS PV Technology
Thin Film PV Technologies CIGS PV Technology Week 5.3 Arno Smets CIGS NiA1 MgF 2 TCO (ZnO:Al) TCO (intrinsic ZnO) CdS (n-type) CuInSe 2 (p-type) Mo Glass CIGS IV- semiconductors: III- V semiconductors:
Chapter 5: Quantization of Radiation in Cavity and Free Space. Classical Electrodynamics: Maxwell s Equations
C 47 Sg 9 Fh Cll vy Ch 5: Quz f Cvy F S I h lu yu wll l: Cll lg Quz f Cvy Quz f F S Fl Cu l Ph Nu S Ph Mu Ph S C 47 Sg 9 Fh Cll vy Cll ly: Mxwll u 4 J Mxwll u: Cvy J u: wh C 47 Sg 9 Fh Cll vy Sl Pl S:
DCP Networks
www.bps.org.uk/dcp DCP Networks To support and promote clinical psychology, working collaboratively with people who use our services and wider communities to improve wellbeing and to promote the unique
Premium Specialty: Pediatrics
Premium Specialty: Pediatrics Credentialed Specialties include: Adolescent Medicine, Pediatric Adolescent, and Pediatrics This document is designed to be used in conjunction with the UnitedHealth Premium
Is thromboprophylaxis effective in reducing the pulmonary thromboembolism?
Is thromboprophylaxis effective in reducing the pulmonary thromboembolism? Fereshteh Rajabi (1), Masoumeh Sadeghi (2), Fereshteh Karbasian (3), Ali Torkan (4) Abstract BACKGROUND: Deep vein thrombosis
To test the possible source of the HBV infection outside the study family, we searched the Genbank
Supplementary Discussion The source of hepatitis B virus infection To test the possible source of the HBV infection outside the study family, we searched the Genbank and HBV Database (http://hbvdb.ibcp.fr),
ALLTRADE FORKLIFT PARTS PTE LTD
ATTENTION PAGE : 1 (HALLA) FAC0300060 FAC0300080 FAC0311070 FAC0311240 FAD0300600 OK675-15-010 OK675-15-082 OS211-15-173 OS213-15-172 QK0905-15 (HANGCA) 053022 053023 198911A 36010-L9000-G00 40DH-512000
ARIC Public Use Data Modified Variable Dictionary - Surveillance
ARIC Public Use Data Modified Variable Dictionary - Surveillance Table of Contents for Year YY a 1. Introduction... 3 2. CSTRPSYY (Stroke Abstraction) 2.1 FUSTR12... 3 2.2 FUSTR14... 3 2.3 FUSTR21... 3
Deselection 2011 QU Biochemistry DISPLAY_CALL_NO TITLE_BRIEF PUB_DATE
DISPLAY_CALL_NO TITLE_BRIEF PUB_DATE QU 4 B347i 1970 Introduction to organic and biological chemistry 1970 QU 4 B361m 1999 Medical biochemistry / 1999 QU 4 B615a2 1981 Biochemistry : a problems approach
Episodes of Care Risk Adjustment
Episodes of Care Risk Adjustment Episode Types Wave 1 Asthma Acute Exacerbation Perinatal Total Joint Replacement Wave 2 Acute Percutaneous Coronary Intervention COPD Acute Exacerbation Non-acute Percutaneous
CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM. Gordon Lowe Professor of Vascular Medicine University of Glasgow
CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM Gordon Lowe Professor of Vascular Medicine University of Glasgow VENOUS THROMBOEMBOLISM Common cause of death and disability 50% hospital-acquired
DVT PROPHYLAXIS IN HOSPITALIZED MEDICAL PATIENTS SAURABH MAJI SR (PULMONARY,MEDICINE)
DVT PROPHYLAXIS IN HOSPITALIZED MEDICAL PATIENTS SAURABH MAJI SR (PULMONARY,MEDICINE) Introduction VTE (DVT/PE) is an important complication in hospitalized patients Hospitalization for acute medical illness
Supplemental Digital Content: Definitions Based on the International Classification of Diseases, Ninth Revision, Clinical Modification
Supplemental Digital Content: Definitions Based on the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) Diagnose and Procedures Codes 1. ICD-9-CM definition of
Icd 10 code for deep venous
Icd 10 code for deep venous thrombosis prophylaxis The Borg System is 100 % Icd 10 code for deep venous thrombosis prophylaxis PE. Pulmonary Embolus. F-10a Factor 10a Inhibitors. PH. Pulmonary. Hypertension.
Cover Page. The handle holds various files of this Leiden University dissertation
Cover Page The handle http://hdl.handle.net/1887/40114 holds various files of this Leiden University dissertation Author: Exter, Paul L. den Title: Diagnosis, management and prognosis of symptomatic and
PATIENT DRIVEN PAYMENT MODEL
Fact Sheet: PDPM Patient Classification Last Revised: 2-14-19 Background Under PDPM, payment is determined through the combination of six payment components. Five of the components are case-mix adjusted,
GSJ Geochemical Reference Samples. Igneous Rock. Sedimentary Rock. For Instrumental analysis. Reference value for environmental analysis -1
GSJ Geochemical Reference Samples Igneous Rock Recommended and preferable (asterisked) values (major elements in % and minor and trace elements in ppm, unless otherwise noted) N. Imai, S. Terashima, S.
OP-14: SIMULTANEOUS USE OF BRAIN COMPUTED TOMOGRAPHY (CT) AND SINUS COMPUTED TOMOGRAPHY (CT)
OP-14: SIMULTANEOUS USE OF BRAIN COMPUTED TOMOGRAPHY (CT) AND SINUS COMPUTED TOMOGRAPHY (CT) Description of Measure This measure calculates the percentage of Brain CT studies with a simultaneous Sinus
How sarcoma/gist research & expert care are organized in Italy
How sarcoma/gist research & expert care are organized in Italy Organization of care Historical migration for medical care PR VA LC VI TV BG LU GR PG CN AL MI Desi o LO PV Alzano Lombardo CO Casalpusterlen
Deep vein thrombosis and its prevention in critically ill adults Attia J, Ray J G, Cook D J, Douketis J, Ginsberg J S, Geerts W H
Deep vein thrombosis and its prevention in critically ill adults Attia J, Ray J G, Cook D J, Douketis J, Ginsberg J S, Geerts W H Authors' objectives To systematically review the incidence of deep vein
Anticoagulation: Novel Agents
Anticoagulation: Novel Agents Scott C. Woller, MD Medical Director, Anticoagulation Management, Intermountain Healthcare Central Region, co-director Venous Thromboembolism Program, Intermountain Medical
ABF and Implications for Coding Helen Nolan
ABF and Implications for Coding Helen Nolan 11 th May 2017 1 ABF explained What is ABF What are DRGs What are MDCs 2 What is Activity Based Funding (ABF) ABF is a way of funding hospitals for the number
SUPPLEMENTARY INFORMATION. Rare independent mutations in renal salt handling genes contribute to blood pressure variation
SUPPLEMENTARY INFORMATION Rare independent mutations in renal salt handling genes contribute to blood pressure variation Weizhen Ji, Jia Nee Foo, Brian J. O Roak, Hongyu Zhao, Martin G. Larson, David B.
A few other notes that may be of use.
A few other notes that may be of use. - Online Version means that the worksheet is done solely on the computer using Microsoft WORD programme. -Except for the listed words and sentences, the main point
Clinical Medical Policy Department Clinical Affairs Division DESCRIPTION
Prothrombin Time/International Normalized Ratio (PT/INR) Monitor for Home Anticoagulation Management [For the list of services and procedures that need preauthorization, please refer to www.mcs.com.pr.
Product Information Packet ZDFRPM21254C 25HP, 1750RPM,3PH,60HZ,2162C,TEFC,FOOT
Product Information Packet ZFPMC HP, 7PM,PH,HZ,C,FC,FOO Copyright ll product information within this document is subject to BB Motors and Mechanical Inc. copyright protection, unless otherwise noted. Product
Clinical Anatomy, Embryology and Imaging BMS 6115C. Summer Semester 2009 Lynn J. Romrell, Ph.D. Course Director. Course Schedule
Anatomy, Embryology and Imaging BMS 6115C Summer Semester 2009 Lynn J. Romrell, Ph.D. Course Director Course Schedule Color codes for course activities: Anatomy Sessions Anatomic Radiology Sessions Embryology
VTE Management in Surgical Patients: Optimizing Prophylaxis Strategies
VTE Management in Surgical Patients: Optimizing Prophylaxis Strategies VTE in Surgical Patients: Recognizing the Patients at Risk Pathogenesis of thrombosis: Virchow s triad and VTE Risk Hypercoagulability
Medical Complications of Pregnancy
Medical Complications of Pregnancy Systems Cardiovascular Pulmonary Endocrine Gastrointestinal Urologic Neurologic Cardiovascular System Physiologic anemia 3:1 increase of plasma volume:rbc mass Treat
Title: Should oral anticoagulant therapy be continued during dental extraction? A meta-analysis
Author s response to reviews Title: Should oral anticoagulant therapy be continued during dental extraction? A meta-analysis Authors: Shuo Yang (sophiasure@163.com) Quan Shi (shiquan3333@sina.cn) Jinglong
Aspects of Hypoglycemia
Aspects of Hypoglycemia Erik T. Paterson 1 M.D. Abstract To two groups of patients the standard six hour oral glucose tolerance test was administered. Over 80 percent of both groups had abnormal responses
!"#$% (Suppl 6): !"OMMQ!"#$%&'()*+, TRKSV!" #$%&'( )*VRT=xPz!"#$%&'()*+,-./0 UMB
=!"#$!"#$% N!"#$%&'()*!" N!"#$%&'()*+,-.$/0123456$()*789: ;< =>?@1ABC8(!"#$%&'("#)*+,-./0123456789:;?@("#ABCDEFGH 456789:;?@A&BC!"&4D@EF!"#$%&'()*+,-./!"0123%4,-./567891:;(?@!"0AB!"#$%&'()*+,!-./"012345!6789:&(;
Venous Thromboembolism. Prevention
Venous Thromboembolism Prevention August 2010 Venous Thromboembloism Prevention 1 1 Expected Practice Assess all patients upon admission to the ICU for risk factors of venous thromboembolism (VTE) and
General Anatomy p. 1 Organization of the Human Body p. 1 Skeleton of the Human Body p. 4 Ossification of the Bones p. 6 Bone Structure p. 8 Joints p.
General Anatomy p. 1 Organization of the Human Body p. 1 Skeleton of the Human Body p. 4 Ossification of the Bones p. 6 Bone Structure p. 8 Joints p. 10 Principal Joints (Immovable) p. 12 Synovial Joints
Supplementary Online Content
Supplementary Online Content Schnabel RB, Aspelund T, Li G, et al. Validation of an atrial fibrillation risk algorithm in whites and African Americans. Arch Intern Med. 2010;170(21):1909-1917. eappendix.
Supplementary appendix
Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Wells JM, Farris RF, Gosdin TA, et al. Pulmonary
Epidemiology of Venous Thromboembolism in the East. Heng Joo NG Department of Haematology Singapore General Hospital Singapore
Epidemiology of Venous Thromboembolism in the East Heng Joo NG Department of Haematology Singapore General Hospital Singapore Early Literature Tinckler LF Br Med J 1964;1:502 Propagating a notion.. Hwang
IPC REVISION WORKING GROUP. Ninth Session Geneva, June 2 to 13, 2003
E IPC/WG/9/3 ORIGINAL: English only DATE: May 23, 2003 WORLD INTELLECTUAL PROPERTY ORGANIZATION GENEVA SPECIAL UNION FOR THE INTERNATIONAL PATENT CLASSIFICATION (IPC UNION) IPC REVISION WORKING GROUP Ninth
Profile of Respondents Phase 1 F2F Focus Group 1
Profile of Respondents Phase 1 F2F Focus Group 1 Name M/F Gender demographic classification Diagnosed with long term chronic healthcare Chronic healthcare minutes of physical activity a week Attitudinal
SCID-I (for DSM-IV-TR) Posttraumatic Stress (JAN 2007) Anxiety Disorders F. 25
SCID-I (for DSM-IV-TR) Posttraumatic Stress (JAN 2007) Anxiety Disorders F. 25 *POSTTRAUMATIC STRESS * Sometimes things happen to people that are extremely upsetting--things like being in a life threatening
Measuring Long-Term Conditions in Scotland - A summary report
Measuring Long-Term Conditions in Scotland - A summary report Introduction This summary report provides insight into: What are the most common long-term conditions in Scotland? What is the population prevalence
IRB protocol Yair Lev, MD 11/25/08
IRB protocol Yair Lev, MD 11/25/08 Abdominal and Pelvic CT as a screening modality for occult malignant disease in unprovoked Venous Thromboembolism: A randomized, controlled prospective study. A. Study
Results from RE-COVER RE-COVER II RE-MEDY RE-SONATE EXECUTIVE SUMMARY
Assessment of the safety and efficacy of dabigatran etexilate (Pradaxa ) in the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and the prevention of recurrent DVT and PE Results from
Supplementary materials for:
Supplementary materials for: Cecil E, Bottle A, Sharland M, Saxena S. Impact of UK primary care policy reforms on short-stay unplanned hospital admissions for children with primary care-sensitive conditions.
% &'!()!" * #!+, ABSTRACT
The effects of blood pressure variations on end-tidal and arterial CO 2 pressure differences in patients undergoing coronary artery bypass graft Alireza Mahoori, MD Ebrahim Hasani, MD Hamid Mehdizadeh,
Anatomical Terminology
Anatomical Terminology Dr. A. Ebneshahidi Anatomy Anatomy : is the study of structures or body parts and their relationships to on another. Anatomy : Gross anatomy - macroscopic. Histology - microscopic.
Clinical implications of deficiencies of protein S, protein C or antithrombin Brouwer, Jan Leendert Pouwel
University of Groningen Clinical implications of deficiencies of protein S, protein C or antithrombin Brouwer, Jan Leendert Pouwel IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's
RESUME Sep National Medical License, Taiwan Oct Board of Interal Medicine, Taiwan Aug Board of Cardiology, Internal Medicine, Taiwan
RESUME Ye-Hsu Lu, M.D. Office Address: No.100, Ziyou 1st Rd., Sanmin Dist., Kaohsiung City 80708, Taiwan TEL: +886-7-3121101 ext. 7741 (Office), +886-918867017 (Cell) FAX: +886-7-3234845 E-mail: yehslu@gmail.com
Drug Class Monograph
Drug Class Monograph Class: Oral Anticoagulants Drug: Coumadin (warfarin), Eliquis (apixaban), Pradaxa (dabigatran), Savaysa (edoxaban), arelto (rivaroxaban) Formulary Medications: Eliquis (apixaban),
5441 E. Williams Circle Tucson, Arizona Phone (520) Fax (520) DIAGNOSTIC RADIOLOGY CODING SHEETS
5441 E. Williams Circle Tucson, Arizona 85711-7412 Phone (520) 790-2900 Fax (520) 790-3200 www.theabr.org DIAGNOSTIC RADIOLOGY CODING SHEETS 2005 C01A MUSCULOSKELETAL (MSK) DISEASE C01B MUSCULOSKELETAL
USE OF FOSPHENYTOIN (CEREBYX ) AND INTRAVENOUS PHENYTOIN (DILANTIN ) IN ADULT PATIENTS
DISCLAIMER: These guidelines were prepared by the Department of Surgical Education, Orlando Regional Medical Center. They are intended to serve as a general statement regarding appropriate patient care
Condition Congestive heart failure I11.0; I13.0; I13.2; I42.0; I50 CO3C Left ventricular dysfunction I50.1; I50.9 E11 1; E11 9
Comparative effectiveness and safety of non-vitamin K antagonists oral anticoagulants (OACs) and warfarin in daily clinical practice: A propensity weighted nationwide cohort study. Supplementary material
SUBJECT: LIMB PNEUMATIC COMPRESSION EFFECTIVE DATE: 06/27/13 DEVICES FOR VENOUS REVISED DATE: 06/26/14 THROMBOEMBOLISM PROPHYLAXIS
MEDICAL POLICY SUBJECT: LIMB PNEUMATIC COMPRESSION PAGE: 1 OF: 5 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical
DOWNLOAD OR READ : WHAT YOYR DR NOT TELL BREAST CANCER PDF EBOOK EPUB MOBI
DOWNLOAD OR READ : WHAT YOYR DR NOT TELL BREAST CANCER PDF EBOOK EPUB MOBI Page 1 Page 2 what yoyr dr not tell breast cancer what yoyr dr not pdf what yoyr dr not tell breast cancer Today, it has been
Matrix Interferences in ICP-MS: Causes, Effects, and Strategies to Reduce or Eliminate Them
Matrix Interferences in ICP-MS: Causes, Effects, and Strategies to Reduce or Eliminate Them Ruth E. Wolf, Ph. D. and Daniel H. Jones HUMAN HEALTH ENVIRONMENTAL HEALTH 2017 2014 PerkinElmer Matrix Effects
Venous thrombo-embolism in people with idiopathic pulmonary fibrosis: a population based study
Venous thrombo-embolism in people with idiopathic pulmonary fibrosis: a population based study Authors: William Dalleywater 1, Helen A Powell 1,,2, Andrew W Fogarty 1, Richard B Hubbard 1, Vidya Navaratnam
Venous Thromboembolism Prophylaxis
Approved by: Venous Thromboembolism Prophylaxis Vice President and Chief Medical Officer; and Vice President and Chief Operating Officer Corporate Policy & Procedures Manual Number: Date Approved January
A Comprehensive Study of TP53 Mutations in Chronic Lymphocytic Leukemia: Analysis of 1,287 Diagnostic CLL Samples
A Comprehensive Study of TP53 Mutations in Chronic Lymphocytic Leukemia: Analysis of 1,287 Diagnostic CLL Samples Sona Pekova, MD., PhD. Chambon Ltd., Laboratory for molecular diagnostics, Prague, Czech
DOWNLOAD OR READ : THE HAPI HEART DIET AND COOKBOOK PDF EBOOK EPUB MOBI
DOWNLOAD OR READ : THE HAPI HEART DIET AND COOKBOOK PDF EBOOK EPUB MOBI Page 1 Page 2 the hapi heart diet and cookbook the hapi heart diet pdf the hapi heart diet and cookbook 10_Eqyptian_gods_10_Plagues.doc
ID NUMBER: CONTACT YEAR: FORM CODE: C E L VERSION G, DATE: 09/28/2015
ARIC Atherosclerosis Risk in Communities COHORT EVET ELIGIBILIT FORM ID UMBER: COTACT EAR: FORM CODE: C E L VERSIO G, DATE: 09/28/2015 ISTRUCTIOS: This form should be completed for all Cohort deaths, hospitalizations,
modified dye uptake assay including formazan test EC 90 not tested plaque reduction assay
Sauerbrei A, Bohn-Wippert K, Kaspar M, Krumbholz A, Karrasch M, Zell R. 2015. Database on natural polymorphisms and resistance-related non-synonymous mutations in thymidine kinase and DNA polymerase genes
Red Comet. Anatomy. *This course is recommended for grades UNIT 1: CELLS, SKIN, & SENSORY ORGANS. (Time Estimate for Content Study 15 hours)
Red Comet Anatomy In this course students will explore the anatomy or structure of the human body. In addition to learning anatomical terminology, students will study and the main systems of the body including
(10) International Publication Number (43) International Publication Date WO 2013/ A3 20 June 2013 ( ) W P O P C T
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International
(Press Release) The Results of Radioactive Material Monitoring of the Surface Water Bodies within Ibaraki Prefecture
(P l) h l f dc Ml M f h fc W Bd h Ib Pfc Fd, Dcb 2, 2011 W E D, E M B, M f h E Dc l: 03-5521-8316 chbd: 03-3581-3351 Dc: b Yhd (x. 6610) Dp Dc: F (x. 6614) Cd: H H (x. 6628) I ccdc h h Cph d M Pl dd b
Nurse Initiated Sequential Compression Device Application Program for Total Knee Replacement Patient
Nurse Initiated Sequential Compression Device Application Program for Total Knee Replacement Patient Cheung Shuk Shan, Susana (APN,O&T, PYNEH) 15 May, 2013 Total Knee Replacement (TKR) TKR is a common
Characterising hepatitis C virus transmission dynamics in a highrisk incarcerated population
Characterising hepatitis C virus transmission dynamics in a highrisk incarcerated population Neil Bretaña, Lies Boelen, Rowena Bull, Suzy Teutsch, Peter White, Andrew Lloyd, Fabio Luciani on behalf of
Deselection 2011 QZ Pathology. DISPLAY_CALL_NO TITLE_BRIEF PUB_DATE LAKESHORE OWNS QZ 4 A Anderson's Pathology. 1985
DISPLAY_CALL_NO TITLE_BRIEF PUB_DATE LAKESHORE OWNS QZ 4 A552 1985 Anderson's Pathology. 1985 QZ 4 A552 1985 Anderson's Pathology. 1985 QZ 4 A552 1990 Anderson's pathology / 1990 QZ 4 A552 1990 Anderson's
Quantitative immunochemical tests: evidence on accuracy and implementation considerations in the Czech MUDr.. Petr Kocna, CSc.
Quantitative immunochemical tests: evidence on accuracy and implementation considerations in the Czech MUDr.. Petr Kocna, CSc. European Digestive Cancer Days, Prague - 26. September 2017 QUANTITATIVE FIT
NEW DEVELOPMENTS IN CATALYSIS
You are now at www.wernerblank.com HOME NEWS PUBLICATIONS LECTURES PATENTS DOWNLOADS NEW DEVELOPMENTS IN CATALYSIS Werner J. Blank King Industries Inc. Science Road Norwalk, CT 06952 USA wblank@kingindustries.com
Fabry Disease X-linked genetic, multi-organ disorder. Fabry disease screening program in Hypertrophic p Cardiomyopathy: preliminary results.
Fabry Disease X-linked genetic, multi-organ disorder Fabry disease screening program in Hypertrophic p Cardiomyopathy: y preliminary results. Globotriaosylceramide, GL3 Brain -galactosidase A Eyes Lactosylceramide